Welcome to the Sealy Institute for Drug DiscoveryDirector’s Message
The Institute for Drug Discovery capitalizes UTMB’s world-class research in infectious disease, neuroscience, and other disciplines for therapeutics development. Through academic and industrial partnerships, we integrate the best interdisciplinary teams to discover small molecules and biologics for treatment of diseases. Our drug discovery for pandemic preparedness is empowered by the Galveston National Laboratory, the largest biosafety-level-4 facility in the world on an academic campus, and well-established pathogen models at UTMB.
We seek collaborations with academia, industry, government, and philanthropy to develop medicines to improve and extend human lives.
Gary Kobinger, PhD, OM, MSC
In the News
Dr. Menachery (@themenacherylab) is an Assistant Professor in the Department of Microbiology & Immunology at UTMB and has been studying coronaviruses (CoVs) since 2010.
The Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), is seeking outstanding, highly creative scientists as Tenure-Track Investigators (equivalent to an assistant or associate professor-level academic faculty) to advance visionary and field-leading basic, translational, and applied research to develop safe and effective novel vaccines and therapeutics against infectious diseases. Expertise in immunology, virology, structural biology, bioengineering, and closely related fields is desired.